GlycoMimetics, Inc. Insider Transactions
GlycoMimetics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Invus Public Equities, L.P.
10 percent owner |
Sell | 756,835 @ $0.22 | $167,185 | 7,209,945 | 07/30/2024 | 07/30/2024 | |
|
Invus Public Equities, L.P.
10 percent owner |
Sell | 363,949 @ $0.24 | $85,637 | 7,966,780 | 07/29/2024 | 07/30/2024 | |
|
Invus Public Equities, L.P.
10 percent owner |
Sell | 258,335 @ $0.24 | $62,440 | 8,330,729 | 07/26/2024 | 07/30/2024 | |
|
Rock Edwin
Chief Medical Officer |
Buy | 115,000 @ $0.27 | $30,717 | 680,403 | 06/21/2024 | 06/24/2024 | |
|
Rock Edwin
Chief Medical Officer |
Buy | 190,000 @ $0.25 | $48,108 | 565,403 | 06/20/2024 | 06/24/2024 | |
|
Hahn Brian M.
SVP Finance, CFO |
Buy | 17,500 @ $0.25 | $4,335 | 70,643 | 06/18/2024 | 06/20/2024 | |
|
Rock Edwin
Chief Medical Officer |
Buy | 30,403 @ $1.38 | $41,956 | 375,403 | 09/22/2023 | 09/25/2023 | |
|
Rock Edwin
Chief Medical Officer |
Buy | 35,000 @ $1.38 | $48,300 | 345,000 | 09/21/2023 | 09/25/2023 | |
|
Hahn Brian M.
SVP Finance, CFO |
Sell | 3,700 @ $1.95 | $7,215 | 53,143 | 05/17/2023 | 05/18/2023 | |
|
JUNIUS DANIEL M
Director |
Buy | 30,000 @ $1.56 | $46,800 | 93,250 | 05/10/2023 | 05/11/2023 | |
|
Johnson Bruce S
SVP & Chief Commercial Officer |
Buy | 13,500 @ $1.57 | $21,195 | 138,980 | 05/08/2023 | 05/09/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 100,000 @ $1.70 | $170,000 | 8,589,064 | 02/24/2023 | 02/28/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 200,000 @ $1.75 | $350,760 | 8,489,064 | 02/23/2023 | 02/23/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 150,000 @ $1.79 | $268,995 | 8,289,064 | 02/22/2023 | 02/23/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 50,000 @ $1.85 | $92,500 | 8,139,064 | 02/21/2023 | 02/23/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 200,000 @ $1.71 | $341,000 | 8,089,064 | 02/17/2023 | 02/17/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 315,266 @ $1.68 | $531,129 | 7,889,064 | 02/16/2023 | 02/17/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 1,000,000 @ $2.16 | $2.16 M | 7,573,798 | 02/15/2023 | 02/17/2023 | |
|
Invus Public Equities, L.P.
10 percent owner |
Buy | 11,451 @ $3.24 | $37,123 | 6,573,798 | 02/09/2023 | 02/13/2023 | |
|
SANDELL SCOTT D
Director |
Sell | 1,648,908 @ $3.12 | $5.14 M | 2,730,334 | 01/26/2023 | 01/27/2023 |
GlycoMimetics, Inc. FAQ's
Who is on GlycoMimetics, Inc.'s Insider Roster?
The list of insiders at GlycoMimetics, Inc. includes Hahn Brian M., Rock Edwin, Invus Public Equities, L.P..
How much insider selling is happening at GlycoMimetics, Inc.?
Insiders have sold a total of 1.38 M GlycoMimetics, Inc. shares in the last 12 months for a total of 315,262 sold.
Which GlycoMimetics, Inc. insiders have been selling company stock?
The following insiders have sold GlycoMimetics, Inc. shares in the last 12 months: Invus Public Equities, L.P. ($315,262),
How much insider buying is happening at GlycoMimetics, Inc.?
Insiders have purchased a total of 322,500 GlycoMimetics, Inc. shares in the last 12 months for a total of 83,159.
Which GlycoMimetics, Inc. insiders have been buying company stock?
The following insiders have purchased GlycoMimetics, Inc. shares in the last 12 months: Hahn Brian M. ($4,335), Rock Edwin ($78,825),